These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21034562)

  • 1. Intracellular CMTM2 negatively regulates human immunodeficiency virus type-1 transcription through targeting the transcription factors AP-1 and CREB.
    Song HS; Shi S; Lu XZ; Gao F; Yan L; Wang Y; Zhuang H
    Chin Med J (Engl); 2010 Sep; 123(17):2440-5. PubMed ID: 21034562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
    Rabbi MF; Saifuddin M; Gu DS; Kagnoff MF; Roebuck KA
    Virology; 1997 Jun; 233(1):235-45. PubMed ID: 9201233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine.
    Rohr O; Schwartz C; Aunis D; Schaeffer E
    J Cell Biochem; 1999 Dec; 75(3):404-13. PubMed ID: 10536364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 (HIV-1) infection and expression in intestinal epithelial cells: role of protein kinase A and C pathways in HIV-1 transcription.
    Kagnoff MF; Roebuck KA
    J Infect Dis; 1999 May; 179 Suppl 3():S444-7. PubMed ID: 10099116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat.
    Krebs FC; Goodenow MM; Wigdahl B
    J Neurovirol; 1997 May; 3 Suppl 1():S28-32. PubMed ID: 9179787
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements.
    Rabbi MF; Al-Harthi L; Roebuck KA
    Virology; 1997 Oct; 237(2):422-9. PubMed ID: 9356353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-chemokine induction of activation protein-1 and cyclic AMP responsive element activation in human myeloid cells.
    Yang YM; Hatch WC; Liu ZY; Du B; Groopman JE
    Cell Growth Differ; 2001 Apr; 12(4):211-21. PubMed ID: 11331250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways.
    Mor-Vaknin N; Torgeman A; Galron D; Löchelt M; Flügel RM; Aboud M
    Virology; 1997 Jun; 232(2):337-44. PubMed ID: 9191847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells.
    Rohr O; Marban C; Aunis D; Schaeffer E
    J Leukoc Biol; 2003 Nov; 74(5):736-49. PubMed ID: 12960235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.
    Tardif MR; Tremblay MJ
    J Virol; 2005 Apr; 79(7):4316-28. PubMed ID: 15767432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes.
    Rutberg SE; Adams TL; Olive M; Alexander N; Vinson C; Yuspa SH
    Oncogene; 1999 Feb; 18(8):1569-79. PubMed ID: 10102627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 transcription by cyclopentenone prostaglandin A1 in Jurkat T lymphocytes.
    Carattoli A; Fortini D; Rozera C; Giorgi C
    J Biol Regul Homeost Agents; 2000; 14(3):209-16. PubMed ID: 11037055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
    Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
    J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV NS3/4A protein activates HIV-1 transcription from its long terminal repeat.
    Wu X; Ishaq M; Hu J; Guo D
    Virus Res; 2008 Jul; 135(1):155-60. PubMed ID: 18433908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells.
    Kinter AL; Poli G; Fauci AS
    Trans Assoc Am Physicians; 1992; 105():36-43. PubMed ID: 1285017
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription.
    Gruters RA; Otto SA; Al BJ; Verhoeven AJ; Verweij CL; Van Lier RA; Miedema F
    Eur J Immunol; 1991 Jan; 21(1):167-72. PubMed ID: 1846814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.